Resultats de la cerca - Maria Werner‐Wasik

Refinar resultats
  1. 1
    Acute and Late Toxicities of Concurrent Chemoradiotherapy for Locally-Advanced Non-Small Cell Lung Cancer

    Acute and Late Toxicities of Concurrent Chemoradiotherapy for Locally-Advanced Non-Small Cell Lung Cancer per Vivek Verma, Charles B. Simone, Maria Werner‐Wasik

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Radiation Dose-Volume Effects in the Esophagus

    Radiation Dose-Volume Effects in the Esophagus per Maria Werner‐Wasik, Ellen Yorke, Joseph O. Deasy, Jiho Nam, Lawrence B. Marks

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Plan Quality and Treatment Efficiency for Radiosurgery to Multiple Brain Metastases: Non-Coplanar RapidArc vs. Gamma Knife

    Plan Quality and Treatment Efficiency for Radiosurgery to Multiple Brain Metastases: Non-Coplanar RapidArc vs. Gamma Knife per Haisong Liu, David W. Andrews, James J. Evans, Maria Werner‐Wasik, Yan Yu, Adam P. Dicker, Wenyin Shi

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiation therapy oncology group study 83-02

    Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiat... per Maria Werner‐Wasik, Charles Scott, Diana F. Nelson, Laurie E. Gaspar, Kevin Murray, Jennifer Fischbach, James S. Nelson, Alan S. Weinstein, Walter J. Curran

    Publicat 1996
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Active Breathing Coordinator reduces radiation dose to the heart and preserves local control in patients with left breast cancer: Report of a prospective trial

    Active Breathing Coordinator reduces radiation dose to the heart and preserves local control in patients with left breast cancer: Report of a prospective trial per Harriet Eldredge-Hindy, Virginia Lockamy, Albert Crawford, Virginia Nettleton, Maria Werner‐Wasik, Joshua Siglin, Nicole L. Simone, K. Sidhu, Pramila R. Anné

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Phase II Study of Cetuximab in Combination With Chemoradiation in Patients With Stage IIIA/B Non–Small-Cell Lung Cancer: RTOG 0324

    Phase II Study of Cetuximab in Combination With Chemoradiation in Patients With Stage IIIA/B Non–Small-Cell Lung Cancer: RTOG 0324 per George R. Blumenschein, Rebecca Paulus, Walter J. Curran, Francisco Robert, Frank V. Fossella, Maria Werner‐Wasik, Roy S. Herbst, P. Doescher, Hak Choy, Ritsuko Komaki

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Decline in Tested and Self-Reported Cognitive Functioning After Prophylactic Cranial Irradiation for Lung Cancer: Pooled Secondary Analysis of Radiation Therapy Oncology Group Randomized Trials 0212 and 0214

    Decline in Tested and Self-Reported Cognitive Functioning After Prophylactic Cranial Irradiation for Lung Cancer: Pooled Secondary Analysis of Radiation Therapy Oncology Group Rand... per Vinai Gondi, Rebecca Paulus, Deborah Watkins Bruner, Christina A. Meyers, Elizabeth Gore, Aaron H. Wolfson, Maria Werner‐Wasik, A. Sun, Hak Choy, Benjamin Movsas

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Quality of Life Supersedes the Classic Prognosticators for Long-Term Survival in Locally Advanced Non–Small-Cell Lung Cancer: An Analysis of RTOG 9801

    Quality of Life Supersedes the Classic Prognosticators for Long-Term Survival in Locally Advanced Non–Small-Cell Lung Cancer: An Analysis of RTOG 9801 per Benjamin Movsas, Jennifer Moughan, Linda Sarna, Corey J. Langer, Maria Werner‐Wasik, Nicos Nicolaou, Ritsuko Komaki, Mitchell Machtay, Todd H. Wasserman, Deborah Watkins Bruner

    Publicat 2009
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Is There a Lower Limit of Pretreatment Pulmonary Function for Safe and Effective Stereotactic Body Radiotherapy for Early-Stage Non-small Cell Lung Cancer?

    Is There a Lower Limit of Pretreatment Pulmonary Function for Safe and Effective Stereotactic Body Radiotherapy for Early-Stage Non-small Cell Lung Cancer? per Matthias Gückenberger, Larry L. Kestin, Andrew Hope, J. Belderbos, Maria Werner‐Wasik, Di Yan, Jan‐Jakob Sonke, J. Bissonnette, Jürgen Wilbert, Ying Xiao, Inga S. Grills

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Phase I Trial Using Proteasome Inhibitor Bortezomib and Concurrent Temozolomide and Radiotherapy for Central Nervous System Malignancies

    Phase I Trial Using Proteasome Inhibitor Bortezomib and Concurrent Temozolomide and Radiotherapy for Central Nervous System Malignancies per Gregory J. Kubicek, Maria Werner‐Wasik, Mitchell Machtay, G. Mallon, Thomas J. Myers, Michael J. Ramirez, David W. Andrews, Walter J. Curran, Adam P. Dicker

    Publicat 2008
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Modeling Local Control After Hypofractionated Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Report From the Elekta Collaborative Lung Research Group

    Modeling Local Control After Hypofractionated Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Report From the Elekta Collaborative Lung Research Group per Nitin Ohri, Maria Werner‐Wasik, Inga S. Grills, J. Belderbos, Andrew Hope, Di Yan, Larry L. Kestin, Matthias Gückenberger, Jan‐Jakob Sonke, Jean-Pierre Bissonnette, Ying Xiao

    Publicat 2012
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    What Is the Best Way to Contour Lung Tumors on PET Scans? Multiobserver Validation of a Gradient-Based Method Using a NSCLC Digital PET Phantom

    What Is the Best Way to Contour Lung Tumors on PET Scans? Multiobserver Validation of a Gradient-Based Method Using a NSCLC Digital PET Phantom per Maria Werner‐Wasik, A. Nelson, Walter Choi, Yoshio Arai, Peter Faulhaber, Patrick T. Kang, Fábio Almeida, Ying Xiao, Nitin Ohri, Kristin D. Brockway, Jonathan Piper, Aaron Nelson

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    A Collaborative Analysis of Stereotactic Lung Radiotherapy Outcomes for Early-Stage Non–Small-Cell Lung Cancer Using Daily Online Cone-Beam Computed Tomography Image-Guided Radiotherapy

    A Collaborative Analysis of Stereotactic Lung Radiotherapy Outcomes for Early-Stage Non–Small-Cell Lung Cancer Using Daily Online Cone-Beam Computed Tomography Image-Guided Radioth... per Inga S. Grills, Andrew Hope, Matthias Gückenberger, Larry L. Kestin, Maria Werner‐Wasik, Di Yan, Jan‐Jakob Sonke, Jean‐Pierre Bissonnette, Jürgen Wilbert, Ying Xiao, J. Belderbos

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Primary Analysis of a Phase II Randomized Trial Radiation Therapy Oncology Group (RTOG) 0212: Impact of Different Total Doses and Schedules of Prophylactic Cranial Irradiation on Chronic Neurotoxicity and Quality of Life for Patients With Limited-Disease Small-Cell Lung Cancer

    Primary Analysis of a Phase II Randomized Trial Radiation Therapy Oncology Group (RTOG) 0212: Impact of Different Total Doses and Schedules of Prophylactic Cranial Irradiation on C... per Aaron H. Wolfson, Kyounghwa Bae, Ritsuko Komaki, Christina Meyers, Benjamin Movsas, C. Le Péchoux, Maria Werner‐Wasik, Gregory M.M. Videtic, Yolanda I. Garces, Hak Choy

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Primary Analysis of Radiation Therapy Oncology Group Study RTOG 0214

    Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Primary Analysis of Radiation Therapy Onco... per Elizabeth Gore, Kyounghwa Bae, Stuart J. Wong, A. Sun, James A. Bonner, Steven E. Schild, Laurie E. Gaspar, J.A. Bogart, Maria Werner‐Wasik, Hak Choy

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Pretreatment FDG-PET Metrics in Stage III Non-Small Cell Lung Cancer: ACRIN 6668/RTOG 0235

    Pretreatment FDG-PET Metrics in Stage III Non-Small Cell Lung Cancer: ACRIN 6668/RTOG 0235 per Nisha Ohri, Fenghai Duan, Mitchell Machtay, Jeremy Gorelick, Bradley S. Snyder, Abass Alavi, Barry A. Siegel, Douglas Johnson, Jeffrey D. Bradley, Albert S. DeNittis, Maria Werner‐Wasik

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Secondary Analysis of RTOG 9508, a Phase 3 Randomized Trial of Whole-Brain Radiation Therapy Versus WBRT Plus Stereotactic Radiosurgery in Patients With 1-3 Brain Metastases; Poststratified by the Graded Prognostic Assessment (GPA)

    Secondary Analysis of RTOG 9508, a Phase 3 Randomized Trial of Whole-Brain Radiation Therapy Versus WBRT Plus Stereotactic Radiosurgery in Patients With 1-3 Brain Metastases; Posts... per Paul W. Sperduto, Ryan Shanley, Xianghua Luo, David W. Andrews, Maria Werner‐Wasik, Richard K. Valicenti, Jean-Paul Bahary, Luís Souhami, Minhee Won, Minesh P. Mehta

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma

    Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients... per Terri S. Armstrong, Jeffrey S. Wefel, Meihua Wang, Mark R. Gilbert, Minhee Won, Andrew Bottomley, Tito R. Mendoza, Corneel Coens, Maria Werner‐Wasik, David Brachman, Ali Choucair, Minesh P. Mehta

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    ALK Inhibitor PF02341066 (Crizotinib) Increases Sensitivity to Radiation in Non–Small Cell Lung Cancer Expressing EML4-ALK

    ALK Inhibitor PF02341066 (Crizotinib) Increases Sensitivity to Radiation in Non–Small Cell Lung Cancer Expressing EML4-ALK per Yunguang Sun, Kamila Nowak, Nicholas G. Zaorsky, Chia-Lin Winchester, Kunal Dalal, Nicholas J. Giacalone, Ningbo Liu, Maria Werner‐Wasik, Mariusz A. Wasik, Adam P. Dicker, Bo Lü

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801

    The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Grou... per Richard, Lawrence Yaacov, Rebecca, Paulus, Corey, Langer, Maria, Werner-Wasik, Buyyounouski Mark, K, Ritsuko, Komaki, Mitchell, Machtay, Colum, Smith, Axelrod Rita, S, Todd, Wasserman, Bradley Jeffrey, D, Benjamin, Movsas

    Publicat 2013
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:

Eines de cerca: